DADC
SANA icon

D.A. Davidson & Co’s Sana Biotechnology SANA Stock Holding History

D.A. Davidson & Co’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,220
Closed -$39.8K – 1598
2025
Q3 		$39.8K Sell
11,220
-2,000
-15% -$7.23K ﹤0.01% 1506
2025
Q2 		$36.1K Sell
13,220
-1,480
-10% -$3.05K ﹤0.01% 1425
2025
Q1 		$24.7K Hold
14,700
– – ﹤0.01% 1391
2024
Q4 		$24K Sell
14,700
-16,880
-53% -$50.3K ﹤0.01% 1404
2024
Q3 		$131K Sell
31,580
-4,000
-11% -$21K ﹤0.01% 1331
2024
Q2 		$194K Buy
35,580
+13,380
+60% +$107K ﹤0.01% 1290
2024
Q1 		$222K Buy
+22,200
New +$166K ﹤0.01% 1270

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $9.64B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $1.89B AUM 112.84% 1-Year Est. Return